Provided by Tiger Trade Technology Pte. Ltd.

PIMCO Municipal Income Fund II

7.01
-0.0005-0.01%
Post-market: 7.010.00000.00%19:30 EDT
Volume:482.14K
Turnover:3.38M
Market Cap:879.53M
PE:8.94
High:7.06
Open:7.02
Low:6.98
Close:7.01
52wk High:8.01
52wk Low:6.98
Shares:125.47M
Float Shares:125.47M
Volume Ratio:1.12
T/O Rate:0.38%
Dividend:0.47
Dividend Rate:6.76%
EPS(TTM):0.7843
EPS(LYR):0.2737
ROE:12.75%
ROA:3.20%
PB:0.86
PE(LYR):25.61

Loading ...

Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Dow Jones
·
Sep 02

Stifel Initiates Pimco Municipal Income Fund II at Buy

MT Newswires Live
·
Aug 31

Bank of America Disposes of PIMCO Municipal Income Fund II Common Shares Worth $735.5

Reuters
·
Aug 21

Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Dow Jones
·
Aug 04

PIMCO Municipal Income Fund II Director Sonya Morris Buys 5,000 Common Shares for $37,500

Reuters
·
Jul 24

PIMCO Municipal Income Fund II Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale

Reuters
·
Jul 09

Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions

Dow Jones
·
Jul 02

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

GlobeNewswire
·
Jun 22

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

GlobeNewswire
·
Jun 03

Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026

GlobeNewswire
·
Jun 01

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

GlobeNewswire
·
Jun 01

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

GlobeNewswire
·
May 27

TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting

GlobeNewswire
·
May 26

Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Dow Jones
·
May 02

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

Director Sonya Morris acquires 5,000 PIMCO Municipal Income Fund II common shares; value rises to $37,389

Reuters
·
Mar 28

Bank of America Corp reports disposal of USD 496 in PIMCO Municipal Income Fund II common shares

Reuters
·
Mar 18

Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis

GlobeNewswire
·
Mar 09